THURSDAY, SEPTEMBER 21, 2017

Adimmune Corporation completes Phase III trials on H7N9 influenza vaccine

H7N9 Virus Read More »

Sanofi begins production of dengue vaccine

Sanofi SA, a French pharmaceutical company, recently began producing an experimental dengue vaccine ahead of authorization from regulators in an attempt to stay ahead of competitors. Read More »

Researchers find new way to vaccinate against flu

Influenza Read More »

New quadruple treatment proves to be effective against two types of cancer

Prostate cancer Read More »

UNAIDS recommends rapid scale up of access to antiretroviral medicines

The Joint United Nations Programme in HIV/AIDS launched a new framework on Saturday that is meant to accelerate action in giving 15 million people access to retroviral treatment by 2015. Read More »

CPE continues to spread throughout Europe

Carbapenemase-producing Enterobacteriaceae, a type antibiotic-resistant bacteria, are continuing to pose a threat to healthcare in Europe, the European Centre for Disease Prevention and Control said on Monday. Read More »

Sabin Vaccine Institute launches vaccine discovery initiative

The Sabin Vaccine Institute Product Development Partnership announced on Monday the launch of its soil-transmitted helminth vaccine discovery program. Read More »

AstraZeneca CFO resigns

AstraZeneca announced yesterday that it's Chief Financial Officer and Executive Director Simon Lowth will resign at the end of the third quarter. Read More »

WHO, RBM and ALMA launch malaria intelligence gathering unit

Malaria Read More »

WHO issues update on Israel poliovirus situation

The World Health Organization issued an update on Monday related to the detection of wild poliovirus type I from environmental samples in Israel, where no cases of paralytic polio were reported. Read More »

New treatment regimens for gonorrhea discovered

Gonorrhea Read More »

TPP may prevent developing nations from accessing generic medications

Médecins Sans Frontières is fighting against the Trans-Pacific Partnership Agreement, which may prevent impoverished regions from gaining access to affordable, generic medications. Read More »

Black-legged ticks connected to encephalitis cases in New York state

black-legged tick Read More »

New MERS-CoV case detected in UAE

Coronavirus Read More »

ECDC gives weekly report on disease threats

The European Centre for Disease Prevention and Control released its Communicable Disease Threats Report on Tuesday. Read More »

France pledges $1.4 billion to Global Fund

The Global Fund to Fight AIDS, Tuberculosis and Malaria warmly accepted on Tuesday President François Hollande of France's contribution of $1.4 billion to the Global Fund for the 2014-2016 period. Read More »

UNICEF boosted innovation in 2012 to reach most vulnerable

The United Nations Children's Fund capitalized on innovation last year to develop partnerships and programs to reach the world's most disadvantaged individuals, according to a recently released report. Read More »

Case of rubella confirmed at Valparaiso University in Indiana

Rubella Read More »

Sequella acquires rights to Sutezolid

Sequella announced on Wednesday that it has acquired exclusive world rights to develop and commercialize Pfizer's Sutezolid. Read More »

HEALTH warns Rhode Islanders to beware of risk of shigella infection

The Rhode Island Department of Health recently warned the public about the risk of shigella infection after roughly 150 people contracted shigellosis, a gastrointestinal illness resulting from Shigella Sonnei bacterium. Read More »